Outcomes in Pregnant Women with Valvular Heart Disease from Portuguese-Speaking African Countries Treated in Portugal through an International Agreement of Health Cooperation
References
- Lawley CM, Algert CS, Ford JB, Nippita TA, Figtree GA, Roberts CL. Heart valve prostheses in pregnancy: Outcomes for women and their infants. J Am Heart Assoc. 2014; 3: 1–8. DOI: 10.1161/JAHA.114.000953
- Zühlke L, Karthikeyan G, Engel ME, et al. Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low-and middle-income countries: Two-year follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY Study). Circulation. 2016; 134: 1456–1466. DOI: 10.1161/CIRCULATIONAHA.116.024769
- Vervoort D, Meuris B, Meyns B, Verbrugghe P. Global cardiac surgery: Access to cardiac surgical care around the world. J Thorac Cardiovasc Surg. 2020; 159: 987–996.e6. DOI: 10.1016/j.jtcvs.2019.04.039
- Liaw J, Walker B, Hall L, Gorton S, White AV, Heal C. Rheumatic heart disease in pregnancy and neonatal outcomes: A systematic review and meta-analysis. PLoS One. 2021; 16: 1–19. DOI: 10.1371/journal.pone.0253581
- Hui C, Lili M, Libin C, et al. Changes in coagulation and hemodynamics during pregnancy: A prospective longitudinal study of 58 cases. Arch Gynecol Obstet. 2012; 285: 1231–1236. DOI: 10.107/s00404-011-2137-x
- Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003; 16: 153–168. DOI: 10.1016/s1521-6926(03)00021-5
- Gilson GJ, Samaan S, Crawford MH, Qualls CR, Curet LB. Changes in hemodynamics, ventricular remodeling, and ventricular contractility during normal pregnancy: A longitudinal study. Obstet Gynecol. 1997; 89: 957–962. DOI: 10.1016/S0029-7844(97)85765-1
- Abbas AE, Lester SJ, Connolly H. Pregnancy and the cardiovascular system. Int J Cardiol. 2005; 98: 179–189. DOI: 10.1016/j.ijcard.2003.10.028
- Poppas A, Shroff SG, Korcarz CE, et al. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation. 1997; 95: 2407–2415. DOI: 10.1161/01.CIR.95.10.2407
- Monteiro AV, Rebelo J, Patricio L, Campos A, Borges A, Ferreira RC. Ten years’ experience of pregnancy outcomes in women with cardiac valvulopathies: Are valve prostheses worst? J Heart Valve Dis. 2015; 24: 368–375.
- Tefera E. Treatment of children with rheumatic heart disease in Sub-Saharan Africa by overseas’ medical missions: Challenges left behind. Res J Cardiol. 2014; 2: 1–6.
- Mocumbi AO. African experiences of humanitarian cardiovascular medicine: the Mozambican experience. Cardiovasc Diagn Ther. 2012; 2(3): 246–251.
- Strategic plan in health cooperation of the community of Portuguese-speaking countries (PECS-CPLP). PECS 2018–2021.
https://www.cplp.org/id-2370.aspx . (Accessed 13 May 2022). - Van Hagen IM, Roos-Hesselink JW, Ruys TPE, et al. Pregnancy in women with a mechanical heart valve: Data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation. 2015; 132: 132–142. DOI: 10.1161/CIRCULATIONAHA.115.015242
- Steinberg ZL, Dominguez-Islas CP, Otto CM, Stout KK, Krieger EV. Maternal and fetal outcomes of anticoagulation in pregnant women with mechanical heart valves. J Am Coll Cardiol. 2017; 69: 2681–2691. DOI: 10.1016/j.jacc.2017.03.605
- Mazibuko B, Ramnarain H, Moodley J. An audit of pregnant women with prosthetic heart valves at a tertiary hospital in South Africa: A five-year experience. Cardiovasc J Afr. 2012; 23: 216–221. DOI: 10.5830/CVJA-2012-022
- Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. ESC Guidelines for the management of cardiovascular diseases during pregnancy. European Heart Journal. 2018; 39: 3165–3241. DOI: 10.1093/eurheartj/ehy340
- Mehta LS, Warnes CA, Bradley E, Burton T, Economy K, Mehran R, et al. Cardiovascular considerations in caring for pregnant patients: A scientific statement from the American Heart Association. Circulation. 2020; 141(23): e884–e903. DOI: 10.1161/CIR.0000000000000772
- Geelani MA, Singh S, Verma A, Nagesh A, Betigeri V, Nigam M. Anticoagulation in patients with mechanical valves during pregnancy. Asian Cardiovascular and Thoracic Annals. 2005; 13(1): 30–33. DOI: 10.1177/021849230501300107
- Al-Lawati AA, Venkitraman M, Al-Delaime T, Valliathu J. Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation. Eur J Cardiothorac Surg. 2002 Aug; 22(2): 223–227. DOI: 10.1016/s1010-7940(02)00302-0
- D’Souza R, Ostro J, Shah PS, Silversides CK, Malinowski A, Murphy KE, et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J. 2017 May 14; 38(19): 1509–1516. DOI: 10.1093/eurheartj/ehx032
- Dhillon SK, Edwards J, Wilkie J, Bungard TJ. High-versus low-dose warfarin-related teratogenicity: A case report and systematic review. J Obstet Gynaecol Can. 2018; 40(10): 1348–1357. DOI: 10.1016/j.jogc.2017.11.020
- McLintock C. Thromboembolism in pregnancy: Challenges and controversies in the prevention of pregnancy-associated venous thromboembolism and management of anticoagulation in women with mechanical prosthetic heart valves. Best practice & research Clinical obstetrics & gynaecology. 2014; 28(4): 519–536. DOI: 10.1016/j.bpobgyn.2014.03.001
- Chalachew T, Yadeta D, Tefera E. Factors associated with sub-optimal control of anticoagulation in patients with prosthetic heart valves taking oral anticoagulants in a sub-Saharan African setting. Cardiovasc J Afr. 2019 May 24; 30(6): 1–5. DOI: 10.5830/CVJA-2019-024
- Nwiloh J, Oludara M, Adebola P, Edaigbini S, Danbauchi S, Sowunmi A. Experience with prosthetic valve replacement in indigents with rheumatic heart disease in Nigeria: 10-year follow-up. World Journal of Cardiovascular Surgery. 2015; 5: 75–81. DOI: 10.4236/wjcs.2015.58013
- Elkayam U. Anticoagulation therapy for pregnant women with mechanical prosthetic heart valves: How to improve safety? J Am Coll Cardiol. 2017 Jun 6; 69(22): 2692–2695. DOI: 10.1016/j.jacc.2017.04.034
- Keepanasseril A, et al. Alternatives to low molecular weight heparin for anticoagulation in pregnant women with mechanical heart valves in middle-income countries: A cohort study. Global Heart. 2021; 16(1): 68. DOI: 10.5334/gh.1011
- Yinon Y, Siu SC, Warshafsky C, Maxwell C, McLeod A, Colman JM, et al. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Am J Cardiol. 2009 Nov 1; 104(9): 1259–1263. DOI: 10.1016/j.amjcard.2009.06.040
- Connolly SJ, Karthikeyan G, Ntsekhe M, Haileamlak A, El Sayed A, El Ghamrawy A, et al; INVICTUS investigators. Rivaroxaban in rheumatic heart disease-associated atrial fibrillation. N Engl J Med. 2022 Sep 15; 387(11): 978–988. DOI: 10.1056/NEJMoa2209051
- Silversides CK, Grewal J, Mason J, et al. Pregnancy outcomes in women with heart disease: The CARPREG II study. J Am Coll Cardiol Elsevier. 2018; 71: 2419–2430. DOI: 10.1016/j.jacc.2018.02.076
- Roos-Hesselink JW, Ruys TPE, Stein JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: Results of a registry of the European Society of Cardiology. Eur Heart J. 2013; 34: 657–665. DOI: 10.1093/eurheartj/ehs270
- Santos F Dos, Baris L, Varley A, et al. Mechanical heart valves and pregnancy: Issues surrounding anticoagulation. Experience from two obstetric cardiac centres. Obstet Med. 2021; 14: 95–101. DOI: 10.1177/1753495X20924937
- Kim WK, Kim HJ, Kim JB, et al. Clinical outcomes in 1731 patients undergoing mitral valve surgery for rheumatic valve disease. Heart. 2018; 104: 841–848. DOI: 10.1136/heartjnl-2017-312249
- Antunes MJ. Repair for rheumatic mitral valve disease. The controversy goes on! Heart. 2018; 104: 796–797. DOI: 10.1136/heartjnl-2017-312674
- Rusingiza EK, El-Khatib Z, Hedt-Gauthier B, Ngoga G, Dusabeyezu S, Tapela N, et al. Outcomes for patients with rheumatic heart disease after cardiac surgery followed at rural district hospitals in Rwanda. Heart. 2018 Oct; 104(20): 1707–1713. DOI: 10.1136/heartjnl-2017-312644
- Tefera E, Nega B, Yadeta D, Chanie Y. Humanitarian cardiology and cardiac surgery in Sub-Saharan Africa: Can we reshape the model? World J Pediatr Congenit Heart Surg. 2016; 7: 727–731. DOI: 10.1177/2150135116668834
- Coates MM, Sliwa K, Watkins DA, Zühlke L, Perel P, Berteletti F, et al. An investment case for the prevention and management of rheumatic heart disease in the African Union 2021-30: A modelling study. Lancet Glob Health. 2021 Jul; 9(7): e957–e966. DOI: 10.1016/S2214-109X(21)00199-6
- Pearce S, Bowen AC, Engel ME, de la Lande M, Barth DD. The incidence of sore throat and group A streptococcal pharyngitis in children at high risk of developing acute rheumatic fever: A systematic review and meta-analysis. PloS one. 2020; 15(11):
e0242107 . DOI: 10.1371/journal.pone.0242107 - Engel ME, Cohen K, Gounden R, et al. The Cape Town clinical decision rule for streptococcal pharyngitis in children. Pediatr Infect Dis J. 2017; 36(3): 250–255. DOI: 10.1097/INF.0000000000001413
DOI: https://doi.org/10.5334/gh.1183 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jul 10, 2022
Accepted on: Jan 12, 2023
Published on: Feb 13, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2023 Vera Vaz Ferreira, André Viveiros Monteiro, Rita Ilhão Moreira, Marta Plancha, Ana Isabel Machado, Alexandra Castelo, Pedro Garcia Brás, Tânia Branco Mano, Maria José Alves, Boban Thomas, Rui Cruz Ferreira, Lino Patrício, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.